Nicht aus der Schweiz? Besuchen Sie lehmanns.de
The Carbonic Anhydrases: Current and Emerging Therapeutic Targets -

The Carbonic Anhydrases: Current and Emerging Therapeutic Targets

Buch | Softcover
XII, 288 Seiten
2022 | 1st ed. 2021
Springer International Publishing (Verlag)
978-3-030-79513-9 (ISBN)
CHF 149,75 inkl. MwSt
  • Versand in 15-20 Tagen
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken

This volume assembles and integrates the wealth of diverse information that is now accumulating in this burgeoning field. The existing and potential therapeutic applications of targeting CA cover a remarkably wide-range of diseases and disorders and have generated increasing and extensive interest in recent years. Its inter-disciplinary approach embraces both the most up-to-date therapeutic application of CA-targeting and the latest research data that will provide a platform for the development of novel applications. The interested audience comprises scientists and clinicians from many relevant disciplines within science and medicine.

Dedication.- Preface.-The carbonic anhydrases in health and disease.- Carbonic anhydrase isozymes as diagnostic biomarkers and therapeutic targets.- Targeting carbonic anhydrases in vascular and pulmonary disease.- Carbonic anhydrase inhibitors in ophthalmology:  glaucoma and macular oedema.- Targeting carbonic anhydrase isozymes in the treatment of neurological disorders.- Potential of carbonic anhydrase inhibitors in the treatment of oxidative stress and diabetes.- An overview of carbonic anhydrase-related neoplasms.- The carbonic anhydrase IX interactome and the regulation of cancer progression.- Carbonic anhydrase IX: current and emerging therapies.- Carbonic anhydrase inhibitors: designing isozyme-specific inhibitors as therapeutic agents.- Carbonic anhydrase inhibitors: identifying therapeutic cancer agents through virtual screening.- Targeting carbonic anhydrase IX in tumour imaging and theranostic cancer therapy.

Erscheinungsdatum
Reihe/Serie Progress in Drug Research
Zusatzinfo XII, 288 p. 38 illus., 22 illus. in color.
Verlagsort Cham
Sprache englisch
Maße 155 x 235 mm
Gewicht 462 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Pharmakologie / Pharmakotherapie
Medizin / Pharmazie Pflege
Medizin / Pharmazie Pharmazie PTA / PKA
Naturwissenschaften Biologie Biochemie
Schlagworte Carbonic Andhydrase • carbonic anhydrase inhibitors • Diabetes • Neurological disorders • Ophthalmology • Therapeutic Cancer Agent
ISBN-10 3-030-79513-6 / 3030795136
ISBN-13 978-3-030-79513-9 / 9783030795139
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich